ArticleJournal of epidemiology and community health2004
Are GP practice prescribing rates for coronary heart disease drugs equitable? A cross sectional analysis in four primary care trusts in England.
Article in Journal of epidemiology and community health, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 50 citations in OpenAlex.
- The Association of Socioeconomic Status (SES) with Procedural Management and Mortality After Percutaneous Coronary Intervention (PCI): An Observational Study from the Pan-London PCI (BCIS) Registry.Journal of cardiovascular development and disease · 2025Article
- Computational drug repositioning of atorvastatin for ulcerative colitis.Journal of the American Medical Informatics Association : JAMIA · 2021Article
- The role of spoken language in cardiovascular health inequalities: a cross-sectional study of people with non-English language preference.BJGP open · 2018Article
- Article
- Equity in healthcare for coronary heart disease, Wales (UK) 2004-2010: A population-based electronic cohort study.PloS one · 2017Article
- Article
- Inequities in access to healthcare: analysis of national survey data across six Asia-Pacific countries.BMC health services research · 2013Article
- Regional differences in self-reported screening, prevalence and management of cardiovascular risk factors in Switzerland.BMC public health · 2012Article
- Correlation between prescribing quality and pharmaceutical costs in English primary care: national cross-sectional analysis.The British journal of general practice : the journal of the Royal College of General Practitioners · 2011Article
- Variations in cardiovascular disease under-diagnosis in England: national cross-sectional spatial analysis.BMC cardiovascular disorders · 2011Article
- Socioeconomic and ethnic differences in use of lipid-lowering drugs after deregulation of simvastatin in the UK: the Whitehall II prospective cohort study.Atherosclerosis · 2011Article
- Influence of population and general practice characteristics on prescribing of minor tranquilisers in primary care.Pharmacy practice · 2010Article
- Practice characteristics and prescribing of cardiovascular drugs in areas with higher risk of CHD in Scotland: cross-sectional study.International journal for equity in health · 2008Article
- Ethnic inequalities in the treatment and outcome of diabetes in three English Primary Care Trusts.International journal for equity in health · 2007Article
- How equitable are GP practice prescribing rates for statins?: an ecological study in four primary care trusts in North West England.International journal for equity in health · 2007Article
- Influence of socioeconomic status on clinical outcomes and quality of life after percutaneous coronary intervention.Journal of epidemiology and community health · 2006Article
- A comparison of methods for calculating general practice level socioeconomic deprivation.International journal of health geographics · 2006Article
- Socioeconomic gradient in use of statins among Danish patients: population-based cross-sectional study.British journal of clinical pharmacology · 2005Article
- Differential associations between actual and expected GP practice prescribing rates for statins, ACE inhibitors, and beta-blockers: a cross-sectional study in England.Therapeutics and clinical risk management · 2005Article
- Exploring the equity of GP practice prescribing rates for selected coronary heart disease drugs: a multiple regression analysis with proxies of healthcare need.International journal for equity in health · 2005Article
Corrections and comments
- Commented on by
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
STUDY
objectiveTo analyse the associations between proxies of healthcare need and GP practice prescribing rates for five major coronary heart disease (CHD) drug groups.
designCross sectional secondary analysis.
settingFour primary care trusts (PCTs 1-4) in the north west of England, encompassing 132 GP practices.
resultsPrescribing rates were generally positively associated with the percentage of patients aged 55-74 years and PASS-PUs (regionally specific prevalence, age, and sex standardised prescribing units). However, the percentage of patients aged over 75 years showed a lack of association with prescribing rates in all PCTs other than PCT2. Correlations with the proportion of South Asian patients were generally negative, particularly in PCT2, PCT4, and the combined dataset. There was a general lack of association with deprivation proxies and SMRs for CHD, although there were negative associations with both variables in PCT4 and the combined dataset. Scatter plots showed that GP practices with similar prescribing rates had widely differing levels of comparative healthcare need, and GP practices with similar levels of healthcare need had widely differing prescribing rates.
conclusionGP prescribing rates in some PCTs were negatively associated with proxies of healthcare need based on patient age (patients aged over 75 years), ethnicity, levels of deprivation, and SMRs for CHD. As such, this study suggests that prescribing rates in these PCTs may be inequitable as they are not positively associated with healthcare need. This study may form the baseline for further studies to assess the effectiveness of the NSF for CHD in reducing the inequities in prescribing rates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.